Inactive Instrument

InterMune Inc Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

16/14/16	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/14/04	Roche : rules out mega deals, open to smaller ones - paper	RE

16/14/16	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/14/04	Roche : rules out mega deals, open to smaller ones - paper	RE
28/14/28	Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	RE
26/14/26	Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	RE
25/14/25	CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	RE
19/14/19	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
07/13/07	NVIDIA Corporation : SAC insider-trading probe could last years	RE
20/13/20	Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	RE
16/13/16	Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	RE
28/12/28	InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	RE
19/12/19	Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	RE
08/12/08	Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	RE
23/12/23	InterMune, Inc. : InterMune posts lower-than-expected revenue	RE

02/14/02	InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	PU
20/14/20	InterMune : Reports Memorandum of Understanding in Connection with Consolidated Delaware Action	PR
05/14/05	InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	PR
28/14/28	InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
28/14/28	INTERMUNE : SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG	BU

04/14/04	Roche : exclut une mega-fusion, ouvert à de plus petits rachats
26/14/26	Wall Street finit dans le vert, le S&P passe un cap
25/14/25	Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P
25/14/25	Wall Street ouvre en hausse avec les M&A et l'Europe
25/14/25	Apple : USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Edward Harrington CEO	Chief Executive Officer	-	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	71	01/04/2002
Carla Fiankan LAW	General Counsel	-	01/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-1.78%	-1.68%	+1.99%	+13.84%	4.84TCr
REVOLUTION MEDICINES, INC.	+0.85%	-0.70%	+465.55%	+579.03%	4.37TCr
BEONE MEDICINES AG	-2.40%	-0.23%	+12.20%	+70.22%	3.95TCr
IQVIA HOLDINGS INC.	-2.01%	-0.85%	+24.95%	+7.51%	3.9TCr
CELLTRION, INC.	-0.50%	+0.85%	+20.60%	+49.65%	3.26TCr
MEDPACE HOLDINGS, INC.	-0.59%	-2.06%	+26.13%	+117.79%	1.61TCr
ASCENDIS PHARMA A/S	+0.38%	-3.23%	-	-	1.63TCr
EUROFINS SCIENTIFIC SE	+0.49%	+0.92%	+4.32%	+22.16%	1.42TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.43%	+4.70%	+79.75%	+29.11%	1.34TCr
Average	-0.67%	+0.49%	+79.44%	+111.17%	2.92TCr
Weighted average by Cap.	-0.91%	+0.59%	+97.63%	+134.68%

Employees

Sector